To investigate whether chronic temporomandibular disorder (TMD) patients showed any changes in swallowing compared to a control group. Moreover, it was examined whether swallowing variables and a valid clinic measure of orofacial myofunctional status were associated.
We have reported previously about the decision of the prestigious National Academy of Medicine (NAM) to convene a committee of experts to examine all aspects of temporomandibular disorders (TMD).
To understand this possible connection, you have to consider how blood pressure is normally controlled by the nervous system.
Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment
An ad hoc committee, under the auspices of the National Academies of Sciences, Engineering, and Medicine's Health and Medicine Division, has been convened to study temporomandibular disorders (TMD) in a project entitled From Research Discoveries to Clinical Treatment.
Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain. They represent a type of "idiopathic" pain disorder, meaning that the cause or causes are unknown, but research over the decade suggests a genetic component contributing to susceptibility.
The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C.&
The Trial of the Class Action brought by Canadian patients who were implanted with Vitek Proplast TMJ implants, against Health Canada, alleging negligent regulation starts on April 1, 2019 in Toronto.
The following article by Roger B. Fillingim, Gary D. Slade, Joel D. Greenspan, Ronald Dubner, William Maixner, Eric Bair, and Richard Ohrbach was published in the journal of Pain, November 2018. We are grateful to Dr. Fillingim for writing the following
We want you to be among the first to know that because of the advocacy efforts of The TMJ Association, the National Academy of Medicine (NAM) will conduct a first-ever study on Temporomandibular Disorders (TMD).